We are excited to be exhibiting at Microbiome Movement Drug Development, taking place June 28-30, 2023 in Boston, USA. Arranta and Vibalogics offer CDMO capabilities from preclinical to clinical and commercial approval for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. [...]The post Join Us! Microbiome Movement Drug Development, June 28-30, 2023, Boston, USA appeared first on ArrantaBio.
Arranta Bio is a Massachusetts-based CDMO that provides services such as mRNA vaccine and microbiome LBP manufacturing for the pharmaceutical industry.